Diagnosis and therapy of interstitial lung diseases;Diagnostik und therapie interstitieller lungenerkrankungen

Deutsche Medizinische Wochenschrift

Volumn 134, Issue 11, 2009, Pages 524-529

  Neurohr, Claus ^a   Behr, J ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Idiopathic pulmonary fibrosis; Interstitial lung diseases; Lung transplantation; Usual interstitial pneumonia

Indexed keywords

ACETYLCYSTEINE; ANTICOAGULANT AGENT; ANTITUSSIVE AGENT; AZATHIOPRINE; BIBF 1120; BOSENTAN; BRAIN NATRIURETIC PEPTIDE; BRONCHODILATING AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETANERCEPT; FG 3019; HEPARIN; HYDROXYCHLOROQUINE; IMATINIB; METHOTREXATE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY INTEGRIN; MONOCLONAL ANTIBODY TRANSFORMING GROWTH FACTOR BETA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PIRFENIDONE; PREDNISOLONE; RAPAMYCIN; RECOMBINANT GAMMA INTERFERON; SD 208; UNCLASSIFIED DRUG;

ALLERGIC PNEUMONITIS; ANAMNESIS; BERYLLIOSIS; BLOOD ANALYSIS; BLOOD CHEMISTRY; BRONCHIOLITIS OBLITERANS; BRONCHOSCOPY; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DRUG DOSE REDUCTION; ECHOCARDIOGRAPHY; EMPHYSEMA; FIBROSING ALVEOLITIS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTIOCYTOSIS X; HUMAN; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LOEFFLER PNEUMONIA; LUNG ALVEOLUS PROTEINOSIS; LUNG BIOPSY; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; LUNG GRANULOMATOSIS; LUNG HEMORRHAGE; LUNG LAVAGE; LUNG TRANSPLANTATION; LYMPHANGIOLEIOMYOMATOSIS; OXIMETRY; PROGNOSIS; PULMONARY HYPERTENSION; REVIEW; SARCOIDOSIS; SCLERODERMA; SPIROMETRY; THORACOSCOPY; THORAX RADIOGRAPHY; TREATMENT DURATION; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DRUG COMBINATION; DUST; LUNG FIBROSIS; METHODOLOGY; PATHOLOGY; RADIOGRAPHY; SMOKING;

ADRENAL CORTEX HORMONES; BRONCHOSCOPY; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY, COMBINATION; DUST; HUMANS; LUNG DISEASES, INTERSTITIAL; LUNG TRANSPLANTATION; PROGNOSIS; PULMONARY FIBROSIS; SMOKING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 62849119121     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0029-1208082     Document Type: Review

References (20)

1. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 2002; 165 (2): 277-304
2. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000; 161 (2 PART 1): 646-64
3. Behr J, Ryu JH. Pulmonary hypertension in interstitial lung disease. Eur Respir J 2008; 31 (6): 1357-1367
4. Bradley B, Branley HM, Egan JJ et al. British Thoracic Society Interstitial Lung Disease Guideline Group, British Thoracic Society Standards of Care Committee; Thoracic Society of Australia; New Zealand Thoracic Society; Irish Thoracic Society. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 2008; 63 Suppl 5: v1-v58
5. Coultras DB, Hubbard R. Epidemiology of idiopathic pulmonary fibrosis. In: Lynch III JP (Hrsg). Idiopathic pulmonary fibrosis, lung biology in health and disease. New York: Marcel Dekker, 2004: 772
6. Demedts M, Behr J, Buhl R et al, IFIGENIA Study Group. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 2005; 353 (21): 2229-2242
7. Demedts M, Wells AU, Antó JM et al. Interstitial lung diseases: an epidemiological overview. Eur Respir J Suppl 2001; 32: 2s-16s (Pubitemid 34755181)
8. Hoyles RK, Ellis RW, Wellsbury J et al. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma. Arthritis Rheum 2006; 54 (12): 3962-3970 (Pubitemid 44955900)
9. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007; 357 (21): 2153-2165
10. Judson MA. Sarcoidosis: clinical presentation, diagnosis, and approach to treatment. Am J Med Sci 2008; 335 (1): 26-33
11. King TEJr . Clinical advances in the diagnosis and therapy of the interstitial lung diseases. Am J Respir Crit Care Med 2005; 172 (3): 268-279 (Pubitemid 41026138)
12. Leuchte HH, Baumgartner RA, Nounou ME et al. Brain natriuretic peptide is a prognostic parameter in chronic lung disease. Am J Respir Crit Care Med 2006; 173 (7): 744-750
13. Madison JM. Hypersensitivity pneumonitis: clinical perspectives. Arch Pathol Lab Med 2008; 132 (2): 195-198
14. Magnussen H, Goeckenjan G, Köhler D et al. Guidelines to long-term oxygen therapy. Pneumologie 2001; 55 (10): 454-464
15. Meyer KC. Bronchoalveolar lavage as a diagnostic tool. Semin Respir Crit Care Med 2007; 28 (5): 546-560
16. Olschewski H, Hoeper MM, Borst MM et al. Diagnosis and therapy of chronic pulmonary hypertension. Pneumologie 2006; 60 (12): 749-771 (Pubitemid 46092570)
17. Orens JB, Estenne M, Arcasoy S et al. International guidelines for the selection of lung transplant candidates: 2006 update - a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006; 25 (7): 745-1557
18. Ryu JH, Daniels CE, Hartman TE et al. Diagnosis of interstitial lung diseases. Mayo Clin Proc 2007; 82 (8): 976-986
19. Swigris JJ, Olson AL, Fischer A et al. Mycophenolate mofetil is safe, well tolerated, and preserves lung function in patients with connective tissue disease-related interstitial lung disease. Chest 2006; 130 (1): 30-36 (Pubitemid 44116838)
20. Travis WD, Hunninghake G, King TEJr et al. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med 2008; 177 (12): 1338-1347 (Pubitemid 351860911)